Medical Discovery News
Science permeates everyday life. Yet the understanding of advances in biomedical science is limited at best. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today for the medicine of tomorrow. Our weekly five-hundred-word newspaper column (http://www.illuminascicom.com/) and two-minute radio show provide insights into a broad range of biomedical science topics. Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine. Each release is designed to stimulate listeners to think, question and appreciate how science affects their health as well as that of the rest of the world. We also delve into significant biomedical discoveries and portray how science (or the lack of it) has impacted health throughout history.
Medical Discovery News
Breakthrough Medical Advances of 2024 are Built on Biomedical Science
963 Breakthrough Medical Advances of 2024 are Built on Biomedical Science
Welcome to Medical Discovery News. I’m Dr David Niesel.
And I’m Dr. Norbert Herzog.
Discoveries in biomedical research drive the advances that help us stay healthier and live longer. We want to highlight a few breakthroughs from this past year.
Semaglutide is a miracle weight loss drug that you may know as Ozempic or Wegovy. They started as diabetes drugs and then researchers noticed they also ease symptoms from other illnesses such as heart disease and even knee pain from arthritis.
Amazingly, we’re close to having drugs that prevent HIV. Lenacapivir is injected twice a year and has a ninety-nine percent HIV prevention rate.
There’s a new drug for schizophrenia, Cobenfy, that targets muscarinic receptors in the brain. Few new drugs have been developed for schizophrenia and this one started as an Alzheimer’s drug.
For Duchenne muscular dystrophy, Duvyzat is a new drug that helps patients regain some mobility. And For cancer, two new treatments are notable. Enhertu is a new drug for HER-two positive breast cancer.
Osimertinnib is a new drug to combat non-small cell lung cancer which usually plagues non-smokers. The drug inhibits EGFR which stimulates cancer cells to grow.
Finally, let’s recognize that xenotropic transplantation using genetically modified pig-grown organs are now being transplanted in humans.
Read and listen to us this year for many more exciting biomedical and medical advances. Maybe living to one hundred twenty isn’t so far off!
We are Drs. David Niesel and Norbert Herzog, at UTMB and Quinnipiac University, where biomedical discoveries shape the future of medicine. For much more and our disclaimer go to medicaldiscoverynews.comor subscribe to our podcast. Sign up for expanded print episodes at www.illuminascicom.com
